197 related articles for article (PubMed ID: 29778528)
1. Molecular modeling, synthesis, antibacterial and cytotoxicity evaluation of sulfonamide derivatives of benzimidazole, indazole, benzothiazole and thiazole.
Naaz F; Srivastava R; Singh A; Singh N; Verma R; Singh VK; Singh RK
Bioorg Med Chem; 2018 Jul; 26(12):3414-3428. PubMed ID: 29778528
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, antibacterial activity, synergistic effect, cytotoxicity, docking and molecular dynamics of benzimidazole analogues.
Srivastava R; Gupta SK; Naaz F; Singh A; Singh VK; Verma R; Singh N; Singh RK
Comput Biol Chem; 2018 Oct; 76():1-16. PubMed ID: 29857255
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, DFT, docking Studies, and antimicrobial evaluation of novel benzimidazole containing sulphonamide derivatives.
Singh K; Singh VK; Mishra R; Sharma A; Pandey A; Srivastava SK; Chaurasia H
Bioorg Chem; 2024 Aug; 149():107473. PubMed ID: 38820940
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of metronidazole-thiazole derivatives as antibacterial inhibitors.
Qin YJ; Wang PF; Makawana JA; Wang ZC; Wang ZN; Yan-Gu ; Jiang AQ; Zhu HL
Bioorg Med Chem Lett; 2014 Nov; 24(22):5279-83. PubMed ID: 25587588
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antimicrobial activity of novel benzoxazine sulfonamide derivatives.
Konda S; Raparthi S; Bhaskar K; Munaganti RK; Guguloth V; Nagarapu L; Akkewar DM
Bioorg Med Chem Lett; 2015 Apr; 25(7):1643-6. PubMed ID: 25754493
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, molecular docking and biological evaluation of metronidazole derivatives containing piperazine skeleton as potential antibacterial agents.
Wang SF; Yin Y; Qiao F; Wu X; Sha S; Zhang L; Zhu HL
Bioorg Med Chem; 2014 Apr; 22(8):2409-15. PubMed ID: 24680059
[TBL] [Abstract][Full Text] [Related]
7. Exploration of in vitro time point quantitative evaluation of newly synthesized benzimidazole and benzothiazole derivatives as potential antibacterial agents.
Bandyopadhyay P; Sathe M; Ponmariappan S; Sharma A; Sharma P; Srivastava AK; Kaushik MP
Bioorg Med Chem Lett; 2011 Dec; 21(24):7306-9. PubMed ID: 22047695
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, docking, ADMET prediction, cytotoxicity and antimicrobial activity of oxathiadiazole derivatives.
Yadav M; Srivastava R; Naaz F; Singh RK
Comput Biol Chem; 2018 Dec; 77():226-239. PubMed ID: 30366286
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antibacterial activity of novel 4-bromo-1H-indazole derivatives as FtsZ inhibitors.
Wang Y; Yan M; Ma R; Ma S
Arch Pharm (Weinheim); 2015 Apr; 348(4):266-74. PubMed ID: 25773717
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, Antimicrobial Evaluation and in Silico Studies of Eugenol-Sulfonamide Hybrids.
Azevedo-Barbosa H; do Vale BP; Guidolin Rossi G; Dos Santos Siqueira F; Bordignon Guterres K; de Campos MMA; Dos Santos T; Anthony Hawkes J; Ferreira Dias D; Neiva Lavorato S; de Souza TB; Teixeira Carvalho D
Chem Biodivers; 2021 May; 18(5):e2100066. PubMed ID: 33829648
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, antimicrobial activity and computational studies of novel azo linked substituted benzimidazole, benzoxazole and benzothiazole derivatives.
Mishra VR; Ghanavatkar CW; Mali SN; Qureshi SI; Chaudhari HK; Sekar N
Comput Biol Chem; 2019 Feb; 78():330-337. PubMed ID: 30639681
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and antimicrobial evaluation of novel benzimidazole-incorporated sulfonamide analogues.
Zhang HZ; He SC; Peng YJ; Zhang HJ; Gopala L; Tangadanchu VKR; Gan LL; Zhou CH
Eur J Med Chem; 2017 Aug; 136():165-183. PubMed ID: 28494254
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, SAR and molecular docking studies of benzo[d]thiazole-hydrazones as potential antibacterial and antifungal agents.
Zha GF; Leng J; Darshini N; Shubhavathi T; Vivek HK; Asiri AM; Marwani HM; Rakesh KP; Mallesha N; Qin HL
Bioorg Med Chem Lett; 2017 Jul; 27(14):3148-3155. PubMed ID: 28539243
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, antibacterial evaluation and molecular docking studies of some new quinoxaline derivatives targeting dihyropteroate synthase enzyme.
El-Attar MAZ; Elbayaa RY; Shaaban OG; Habib NS; Abdel Wahab AE; Abdelwahab IA; El-Hawash SAM
Bioorg Chem; 2018 Feb; 76():437-448. PubMed ID: 29275262
[TBL] [Abstract][Full Text] [Related]
15. meso-Dihydroguaiaretic acid derivatives with antibacterial and antimycobacterial activity.
Reyes-Melo K; García A; Romo-Mancillas A; Garza-González E; Rivas-Galindo VM; Miranda LD; Vargas-Villarreal J; Favela-Hernández JMJ; Camacho-Corona MDR
Bioorg Med Chem; 2017 Oct; 25(20):5247-5259. PubMed ID: 28844400
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
Lv PC; Wang KR; Yang Y; Mao WJ; Chen J; Xiong J; Zhu HL
Bioorg Med Chem Lett; 2009 Dec; 19(23):6750-4. PubMed ID: 19836235
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Antibacterial Activity, Interaction with Nucleobase and Molecular Docking Studies of 4-Formylbenzoic Acid Based Thiazoles.
Laczkowski KZ; Biernasiuk A; Baranowska-Laczkowska A; Misiura K; Malm A; Plech T; Paneth A
Med Chem; 2016; 12(6):553-62. PubMed ID: 26833073
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Antimicrobial Activity of the Hybrid Molecules between Sulfonamides and Active Antimicrobial Pleuromutilin Derivative.
Chen L; Yang D; Pan Z; Lai L; Liu J; Fang B; Shi S
Chem Biol Drug Des; 2015 Aug; 86(2):239-45. PubMed ID: 25431015
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antibacterial activity of substituted 1,2,3,4-tetrahydropyrazino [1,2-a] indoles.
Tiwari RK; Singh D; Singh J; Yadav V; Pathak AK; Dabur R; Chhillar AK; Singh R; Sharma GL; Chandra R; Verma AK
Bioorg Med Chem Lett; 2006 Jan; 16(2):413-6. PubMed ID: 16246547
[TBL] [Abstract][Full Text] [Related]
20. Scalable synthesis and antibacterial evaluation of 2-(3-(N-(substituted phenyl)sulfamoyl)ureido)benzothiazoles.
Cheraiet Z; Meliani S; Nessaib M; Hessainia S; Boukhari A; Djahoudi A; Regainia Z
Arch Pharm (Weinheim); 2019 Aug; 352(8):e1800341. PubMed ID: 31245880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
